Tuesday, October 15, 2019

Drug companies have a ‘target on their back and very few friends to protect them’ after a shift from the Trump administration. 3 could be especially at risk.

Author

Categories

Share

The Trump administration just yanked a policy that it had proposed earlier this year in an effort to bring down the cost of prescription drugs for patients.
The Trump proposal would have banned payments called rebates in two government-funded health progra…
Read More

Author

Share

error: Content is protected !!